Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Helsinn Group, a company focused on building quality cancer care, today announces that Phase III data from the largest trial program of its kind to...
Le Groupe Helsinn est ravi d'annoncer que le Dr Riccardo Braglia, PDG du Groupe Helsinn, donnera une vue d'ensemble du Groupe Helsinn, ainsi que de...
Helsinn Group se complace al anunciar que mañana (martes 8 de enero de 2013), a las 9am PST (18:00 hora de Suiza), el doctor Riccardo Braglia,...
Helsinn Group is pleased to announce that tomorrow (Tuesday, January 8th, 2013) at 9am Pacific Standard Time (18:00 Swiss time), Dr. Riccardo...
Le groupe pharmaceutique suisse Helsinn Group annonce aujourd'hui que Taiho Pharmaceutical Co. Ltd., concessionnaire japonais du palonosétron de...
La compañía farmacéutica suiza Helsinn Group anuncia hoy que Taiho Pharmaceutical Co. Ltd., el licenciatario japonés del antagonista receptor 5-HT3...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.